Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism
Status:
Completed
Trial end date:
2011-08-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability and efficacy of
multiple ascending doses of etelcalcetide in hemodialysis patients for the treatment of
secondary hyperparathyroidism (HPT).